Navigation Links
Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials
Date:9/28/2007

disease in two, non-treated tumours at one, two and three months post treatment.

The squamous cell scalp patient experienced stable disease in the target tumour for two months which then became a partial response at three months. This patient also experienced stable disease in one non-treated tumour measured at three months post-treatment. Patients in the Ib portion received either two, four or six intratumoural doses of REOLYSIN at 1x1010 TCID50 with a constant localized radiation dose of 36 Gy given in 12 fractions. Of the six patients who have completed the study to date, three patients (colorectal, melanoma and lung cancer) experienced tumour regression in the target tumour, as well as stable disease in non-treated tumours.

The colorectal patient experienced a partial response with a more than 50% regression in the target tumour as well as stable disease in four, non-treated tumours measured at one month following treatment. A melanoma patient experienced minor regression in the target tumour as well as stable disease in two, non-treated tumours at one and two months following treatment. A lung cancer patient experienced minor regression in the target tumour, as well as stable disease in three, non-treated tumours at two months following treatment.

The treatment has been well tolerated, with mostly Grade 1 or 2 toxicities noted including fatigue, lymphopenia, fever, and neutropenia. Grade 3 toxicities including cellulitis, dysphasia and diarrhoea were related to disease progression and not to the combination treatment. Viral replication was unaffected by cellular irradiation.

The primary objective of the Phase Ia/Ib trial is to determine the maximum tolerated dose (MTD), dose limiting toxicity (DLT), and safety profile of REOLYSIN when administered intratumourally to patients receiving radiation treatment. A secondary objective is to examine any evidence of anti-tumour activity. Eligible patients include those who have been diagnosed
'/>"/>

Contact: Cathy Ward
cathy.ward@oncolytics.ca
403-670-7370
Oncolytics Biotech Inc.
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Biotechnology industry expected to grow into a three billion dollar industry by 2002
2. Biotechnology on the lead
3. Panacea Biotech To Market Anthrax Vaccine
4. Commercialization of Biotech Discoveries, An Encouragement For Researchers
5. Biotech drug causing anemia-EPREX
6. Leading Biotech Companies Are Interested In Acquisition Of Smaller Companies
7. Biologicals Transfer Proposal between US and Indian Biotechnology
8. Finland and India to interact and cooperate in the filed of telemedicine and biotechnology
9. Vical Biotech and NIH jointly develops HIV vaccine
10. Biotechnology Initiatives Planned In Hyderabad
11. Biotech Osiris to go public
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2015)... Cruz, california (PRWEB) February 28, 2015 In ... ever growing number of practicing physicians as a way for ... training or education regarding Cannabis as medicine. Since the FDA ... been very few resources available to licensed physicians that ... to a patient. Dr. Deborah Malka in Santa Cruz, ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 The Heart ... now a distributor of the machine. The Heart Fit ... their license, like a franchise model. The goal is ... and reverse heart disease. To buy External Counterpulsation ... Clinic can help individuals through this process and achieve ...
(Date:2/28/2015)... Indosoft Inc , developers of Q-Suite, ... pleased to announce the development of Q-Suite 5.9. Building ... of Q-Suite, this new version will include enhancements to ... features to the leading edge call center software. General ... add features to enhance security and protection. Administrators will ...
(Date:2/28/2015)... Louis, MO (PRWEB) February 28, 2015 ... leading provider of outsourced sales, marketing and supply ... their client, BIOTA Botanicals, is bringing its award ... Celebrated worldwide, BIOTA Botanicals’ products are specifically created ... herbal care experts, BIOTA is committed to marrying ...
(Date:2/28/2015)... How would you describe your ... are all kinds of different leaders, each with ... the advantages and applications of different leadership styles, ... new product this spring called The Leadership Report ... between personality type, leadership, and success. The Leadership ...
Breaking Medicine News(10 mins):Health News:Reputable Cannabis Doctor In Santa Cruz and Monterey Joins the Medical Cannabis Network 2Health News:Clinicians Can Now Purchase External Counterpulsation with Heart Fit Clinic 2Health News:Indosoft Proudly Announces Q-Suite 5.9 Call Center Software for Asterisk 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 2Health News:BIOTA Botanicals Brings Thinning-Damaged Hair Solutions to the Hair Care Aisle at Walgreens 3Health News:PeopleKeys Launches The Leadership Report 2Health News:PeopleKeys Launches The Leadership Report 3
... Three-fourths opt for breast-conserving treatments instead, study finds, , TUESDAY, ... women diagnosed with breast cancer are not turning to mastectomy ... more conservative approaches, such as lumpectomy, a new survey has ... of the Journal of the American Medical Association , ...
... ... Network. , ... October 13, 2009 -- Agilex Technologies, Inc. , an enterprise application, solution and advisory ... today announced the appointment of Melissa Chapman to the newly-created position of Vice President for ...
... Red Mango, the fastest-growing retailer of authentic nonfat ... flavor, Pumpkin Spice , to celebrate the favorite ... to discover Pumpkin Spice frozen yogurt, available ... time, beginning today, October 13, through December 31, 2009. ...
... , The Institute for Palliative Medicine in San ... first statewide consultative service for palliative care ... professionals in California communities lacking palliative medicine resources ... educational support through a new hotline provided by The ...
... Electronics (NYSE: PHG, AEX: PHI) today introduced the next ... at Medtrade 2009, the leading conference and expo ... the new product line brings significant advancements in therapy ... to healthcare providers to help meet today,s healthcare challenges. ...
... "bubble boy" and many will recall David Vetter, the kid with ... 25 years ago after spending almost the entire 12 years of ... with severe combined immune deficiency, or SCID, a condition that robbed ... however, researchers have refined treatment options for children with SCID, and ...
Cached Medicine News:Health News:Mastectomy Not First Choice for Most Breast Cancer Patients 2Health News:Mastectomy Not First Choice for Most Breast Cancer Patients 3Health News:Agilex Technologies Hires Former HHS CIO Melissa Chapman to Lead Health Technology Programs 2Health News:Agilex Technologies Hires Former HHS CIO Melissa Chapman to Lead Health Technology Programs 3Health News:Discover Red Mango's New Seasonal Flavor: Pumpkin Spice 2Health News:New Palliative Medicine Hotline Reaches California 2Health News:New Palliative Medicine Hotline Reaches California 3Health News:Video: Philips Unveils Intelligent Sleep Apnea Therapy System to Home Healthcare Industry 2Health News:Video: Philips Unveils Intelligent Sleep Apnea Therapy System to Home Healthcare Industry 3Health News:Video: Philips Unveils Intelligent Sleep Apnea Therapy System to Home Healthcare Industry 4Health News:Video: Philips Unveils Intelligent Sleep Apnea Therapy System to Home Healthcare Industry 5Health News:SCID kids leading healthy, normal lives 25 years after 'Bubble Boy' 2Health News:SCID kids leading healthy, normal lives 25 years after 'Bubble Boy' 3
(Date:2/27/2015)... -- Acsis Inc., the market leader for supply chain visibility, ... John DiPalo , Acsis, Chief Strategy Officer, has been ... 2015 Provider Pro to Know. The award recognizes ... prepare their companies, and customers, supply chains for the ... of Provider Pros to Know is featured in ...
(Date:2/27/2015)... 27, 2015 Securities lawyers at Dunnam ... Pharmaceuticals, Ltd. (NASDAQ: SLXP ) in connection ... SLXP investors are encouraged to contact attorney Hamilton Lindley ... investigation focuses upon the shareholder value of the transaction. ... receive only $158.00 per share in cash. At least ...
(Date:2/27/2015)... , Feb. 27, 2015 An aggressive campaign ... cut the rate of infection with a dangerous drug-resistant ... Clostridium difficile, or C.diff, is a bacterium ... inflammation of the colon. A recent article in the ... difficile Infection in the United States ...
Breaking Medicine Technology:Acsis CSO John DiPalo Named Supply & Demand Chain Executive 2015 Pro to Know 2Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 2Curb Overuse Of Antibiotics To Reduce Drug-Resistant Superbug 3
... 28 Draeger Medical, Inc., an ... sponsoring a series of educational webinar events designed for ... Clinical Engineers, Biomedical Engineers and other key stakeholders in ... and deployment of wireless patient care solutions within their ...
... Who would,ve guessed that among all the tragic ... that a brain tumor patient would be treated ... is helping out by donating the treatment, care, ... with a pituitary gland tumor. ( www.cyberknifemiami.com ) ...
Cached Medicine Technology:Draeger Announces Sponsorship of Educational Initiatives Focusing on Wireless Advances for Healthcare 2CyberKnife Center of Miami Lends a Hand in Treatment of Haitian Nurse 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: